Park National Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,438
Closed -$277K 406
2025
Q4
$277K Buy
5,438
+517
+11% +$26.4K 0.01% 273
2025
Q3
$273K Buy
4,921
+911
+23% +$53.3K 0.01% 266
2025
Q2
$277K Sell
4,010
-703
-15% -$47.8K 0.01% 255
2025
Q1
$327K Sell
4,713
-53
-1% -$4.38K 0.01% 237
2024
Q4
$410K Sell
4,766
-64
-1% -$6.92K 0.02% 223
2024
Q3
$575K Sell
4,830
-89
-2% -$11.9K 0.02% 202
2024
Q2
$702K Buy
4,919
+487
+11% +$64.5K 0.03% 186
2024
Q1
$569K Sell
4,432
-289
-6% -$34.4K 0.02% 198
2023
Q4
$488K Sell
4,721
-127
-3% -$12.6K 0.02% 205
2023
Q3
$441K Sell
4,848
-46
-0.9% -$4.05K 0.02% 213
2023
Q2
$396K Sell
4,894
-190
-4% -$15.5K 0.02% 222
2023
Q1
$405K Hold
5,084
0.02% 213
2022
Q4
$344K Buy
5,084
+38
+0.8% +$2.23K 0.02% 221
2022
Q3
$251K Sell
5,046
-652
-11% -$34.9K 0.01% 233
2022
Q2
$317K Buy
5,698
+1,984
+53% +$110K 0.02% 222
2022
Q1
$206K Buy
+3,714
New +$191K 0.01% 272
2016
Q3
Sell
-7,744
Closed -$208K 350
2016
Q2
$208K Buy
+7,744
New +$212K 0.01% 326
2016
Q1
Sell
-7,950
Closed -$231K 346
2015
Q4
$231K Buy
+7,950
New +$220K 0.02% 285

Other funds holding NVO

Park National Corp's NVO Position: Q1 2026 in Review

Park National Corp sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,438 shares — an estimated $277K sold.

Park National Corp first reported a position in NVO in Q4 2015 and held it in 18 quarters. The position peaked at $702K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Park National Corp reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Park National Corp sold 5,438 Novo Nordisk shares in Q1 2026, an estimated $277K.
  • Park National Corp first reported a position in Novo Nordisk in Q4 2015 and held it in 18 quarters.
  • Park National Corp's Novo Nordisk position peaked at $702K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Park National Corp's 13F filing for Q1 2026, filed 16 Apr 2026.